newsfilter
← Latest News
GlobeNewswire·

BioDelivery Sciences International to Host ELYXYB™ Investor Day

The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults Virtual Event on October 14, 2021 RALEIGH, N.C., Sept. 30, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International,